Skip to content

Use of Closed-loop Anesthesia in Pediatric Patients

Target-Controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by the Index Bispectral: Comparison in Pediatric Patients Between Manual Perfusion and Automated Perfusion

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00778505
Acronym
LoopPed
Enrollment
45
Registered
2008-10-23
Start date
2008-10-31
Completion date
2012-12-31
Last updated
2016-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Keywords

Anesthesia

Brief summary

To compare manual administration of propofol and remifentanil and dual closed-loop using bispectral index as the control variable during pediatric anesthesia

Interventions

DRUGPropofol

closed-loop administration using bispectral index as the controller

DRUGremifentanil

closed-loop administration using bispectral index as the controller

DRUGRemifentanil

manual administration according bispectral index values

Sponsors

Hopital Foch
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
6 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* class ASA I, II or III * general anesthesia scheduled to last more than one hour * intraoperative hemorrhage planned to be less than 15% of the blood volume

Exclusion criteria

* Combined general and regional anesthesia, * Patients with a pacemaker or scheduled for a cardiac or brain surgical procedure, * History of a neurological or a psychiatric disorder, or central brain lesion, * Patients receiving a psychotropic treatment or a a morphine agonist-antagonist, * Allergy to latex, propofol, remifentanil, morphine, muscle relaxant, or to a component, * Hypersensibility to remifentanil or to a derivate of fentanyl, * Scheduled postoperative ventilation or sedation.

Design outcomes

Primary

MeasureTime frame
Percentage of time during which the bispectral index is between 40 and 60anesthesia

Secondary

MeasureTime frame
propofol and remifentanil dosesanesthesia

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026